5-(2,6-Difluorobenzoyl)-7-(trifluoromethyl)-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinoxaline

Catalog No. :
ACFXWF216
CAS No. :
861206-91-9
Molecular Formula :
C19H15F5N2O
Molecular Weight :
382.33

IUPAC Name:(2,6-difluorophenyl)(7-(trifluoromethyl)-2,3,3a,4-tetrahydropyrrolo[1,2-a]quinoxalin-5(1H)-yl)methanone

5-(2,6-Difluorobenzoyl)-7-(trifluoromethyl)-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$282.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(2,6-Difluorobenzoyl)-7-(trifluoromethyl)-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinoxaline
IUPAC Name(2,6-difluorophenyl)(7-(trifluoromethyl)-2,3,3a,4-tetrahydropyrrolo[1,2-a]quinoxalin-5(1H)-yl)methanone
Molecular FormulaC19H15F5N2O
Molecular Weight382.33
SMILESO=C(C1=C(F)C=CC=C1F)N2CC(CCC3)N3C4=C2C=C(C(F)(F)F)C=C4
InChI KeyKYGCXQFFOYZMDN-UHFFFAOYSA-N
Synonym(2,6-DIFLUOROPHENYL)[7-(TRIFLUOROMETHYL)-2,3,3A,4-TETRAHYDROPYRROLO[1,2-A]QUINOXALIN-5(1H)-YL]METHANONE;5-(2,6-difluorobenzoyl)-7-(trifluoromethyl)-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinoxaline;Methanone, (2,6-difluorophenyl)[2,3,3a,4-tetrahydro-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxalin-5(1H)-yl]-
CAS No.861206-91-9

Synthetic Route by SureRoute

1. ACFXWF216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFXWF216 route product structure diagram
    ACFXWF216861206-91-9
Inquiry

2. ACFXWF216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWPEV903 route compound structure diagram
    ACWPEV903385-00-2 In Stock
  4. Then
  5. ACFXWF216 route product structure diagram
    ACFXWF216861206-91-9
Inquiry

Comments (0)